Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.

We determined the in vitro antimycobacterial activity of rifampicin, isoniazid and a third agent in combination using a three-dimensional chequerboard in Middlebrook 7H9 broth microdilutions. Of 28 agents screened, ethambutol, streptomycin, clarithromycin, minocycline, ciprofloxacin, levofloxacin, sparfloxacin, gatifloxacin and sitafloxacin were potentially synergistic. A further three-dimensional chequerboard assay quantitatively looked for synergy against ten clinical isolates of Mycobacterium tuberculosis, including seven multidrug-resistant isolates. Sitafloxacin, gatifloxacin and clarithromycin showed significant synergy, with fractional inhibitory concentration indices ranging from 0.41 to 0.79, 0.39 to 0.90 and 0.48 to 0.95, respectively. It is concluded that three-dimensional chequerboard assay can quantitatively determine antimycobacterial synergy, and that fluoroquinolones and antibacterial agents such as clarithromycin are effective against multidrug-resistant isolates of M. tuberculosis when combined with rifampicin and isoniazid.

[1]  R. Wallace,,et al.  Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth , 1986, Journal of clinical microbiology.

[2]  J. Bosso,et al.  Comparison of methods of interpretation of checkerboard synergy testing. , 2002, Diagnostic microbiology and infectious disease.

[3]  C. Dye.  Tuberculosis 2000-2010: control, but not elimination. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[4]  V. Yu,et al.  Synergistic interaction in vitro with use of three antibiotics simultaneously against Pseudomonas maltophilia. , 1980, The Journal of infectious diseases.

[5]  P. Fernandes,et al.  In vitro and in vivo activities of clarithromycin against Mycobacterium avium , 1989, Antimicrobial Agents and Chemotherapy.

[6]  M. Ruiz,et al.  Synergic activity of fluoroquinolones and linezolid against Mycobacterium tuberculosis. , 2003, International journal of antimicrobial agents.

[7]  P. Carpentier.  Nouvelles m??thodes d????valuation clinique de la microcirculation cutan??e , 1999 .

[8]  Henry D. Isenberg,et al.  Clinical Microbiology Procedures Handbook , 2004 .

[9]  M. Berenbaum,et al.  A method for testing for synergy with any number of agents. , 1978, The Journal of infectious diseases.

[10]  P. Nassos,et al.  Therapeutic implications of inhibition versus killing of Mycobacterium avium complex by antimicrobial agents , 1987, Antimicrobial Agents and Chemotherapy.

[11]  P. Gangadharam,et al.  In vitro activity of the benzoxazinorifamycin KRM-1648 against drug-susceptible and multidrug-resistant tubercle bacilli , 1995, Antimicrobial agents and chemotherapy.

[12]  T. Shimizu,et al.  Anti-Mycobacterium tuberculosis activities of new fluoroquinolones in combination with other antituberculous drugs. , 2002, The Journal of infection.

[13]  S. Franzblau,et al.  Minocycline in lepromatous leprosy. , 1995, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

[14]  P. Gangadharam,et al.  Antituberculosis activity of clarithromycin , 1995, Antimicrobial agents and chemotherapy.

[15]  G. Alangaden,et al.  The clinical use of fluoroquinolones for the treatment of mycobacterial diseases. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  D. Snider,et al.  The neglected global tuberculosis problem: a report of the 1992 World Congress on Tuberculosis. , 1994, The Journal of infectious diseases.

[17]  H. Tomioka,et al.  Comparative In Vitro Antimicrobial Activities of the Newly Synthesized Quinolone HSR-903, Sitafloxacin (DU-6859a), Gatifloxacin (AM-1155), and Levofloxacin againstMycobacterium tuberculosis and Mycobacterium avium Complex , 1999, Antimicrobial Agents and Chemotherapy.

[18]  H. David,et al.  Intrinsic resistance of Mycobacterium tuberculosis to clarithromycin is effectively reversed by subinhibitory concentrations of cell wall inhibitors. , 2000, The Journal of antimicrobial chemotherapy.

[19]  C. Urban,et al.  In Vitro Double and Triple Synergistic Activities of Polymyxin B, Imipenem, and Rifampin against Multidrug-Resistant Acinetobacter baumannii , 2004, Antimicrobial Agents and Chemotherapy.